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BACKGROUND : 
Optimal management of patients on anti platelet and anti coagulant who 
require oral surgery procedure has been controversial. Historically the surgeons have 
to balance the risk of thromboembolism by reducing or stopping anti platelet and 
anticoagulant therapy, against the risk of triggering excessive post extraction bleeding 
if anticoagulation or anti platelet is maintained at therapeutic levels during surgery. 
Patients on anti platelet and anticoagulants have impaired fibrin formation that is 
more susceptible to normal fibrinolysis and is believed to be the major cause of post 
extraction bleeding. In this study the “Efficacy of tranexamic acid mouth rinse as a 
haemostatic agent after extraction in patients who are on anticoagulant and anti 
platelet therapy” has been studied. 
AIMS AND OBJECTIVE: 
The aim of this study is to verify that this technique is a safe, simple, effective 
and an acceptable method of patient management. The objective is to identify 
potential risk factors that may increase the likelihood of bleeding. 
MATERIALS AND METHODS: 
One hundred consecutive anti platelet and anti coagulant patients  with an 
International Normalized Ratio (INR) ranges between 1.9 and 3.5  on the day of 
surgery and who required dental extractions were recruited to this study. Following 
dental extraction, patients were instructed to use 5 milliliters of 10% tranexamic acid 
mouth rinse 4 times a day for 7 days, to record bleeding that required pressure to 
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control and their mouth rinse usage. The researcher collected demographic data, 
details of the state of anti platelet and anticoagulation, details of the surgery and 
details of bleeding that required additional management. Data entry and analysis were 
conducted using the statistical computer programme SPSS (16.0). Descriptive 
statistics were produced for the sample demographics, the pre extraction profile, the 
post extraction bleeding profile, mouth rinse acceptance and utilization. Identification 
of potential risks that might increase the likelihood of bleeding was carried out using 
the paired and unpaired t test appropriate.  
RESULTS: 
Of the 100 patients treated, 17 reported bleeding at home on day 1 and 3 
patients after day 1. The bleeding reported on these 20 patients was controlled at 
home only by tranexamic acid pressure pack alone. A further 9 patients reported to 
the researcher's dental surgery department for bleeding which was then controlled by 
administering other local haemostatic measures ( gelatin foam ) with tranexamic acid 
pressure pack. No patients required hospital admission for systemic management of 
bleeding. 
       Statistical analysis reveals significant risk factors for post extraction bleeding 
were as follows: 
 Patients in the age group of  41-60;  
 Pre extraction INR equal to and greater than 2.5 ;  
 Smoking.   
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Factors not statistically significant for an increased risk of bleeding included:  
 The number of teeth removed;  
 Pre-extraction bleeding time and 
 Time on anti platelets and anticoagulants. 
CONCLUSION : 
On the basis of research and statistical analysis, it can be concluded that the 
post-operative use of tranexamic acid mouth rinses in patients who underwent dental 
extraction at therapeutic INR levels is a safe, simple, effective and  an acceptable 
method of reducing post extraction bleeding. 
Keywords : Antiplatelet, Anticoagulant, Post Extraction Bleeding, Hemostasis, 
Tranexamic Acid. 
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An increasing number of patients requiring oral surgery are on long-term anti 
platelet   and anticoagulant therapy. While a number of dental management protocols 
had been suggested, but still controversy remains. The clinician must balance the risk 
of thromboembolism by reducing or stopping anti platelet and anticoagulant therapy 
against the risk of triggering excessive post extraction bleeding if anti platelet and 
anticoagulation is maintained at therapeutic levels during surgery.
1
 
Oral anticoagulants and anti platelets  are widely used for primary prevention 
of thromboembolic events in patients with atrial fibrillation and prosthetic heart 
valves and secondary prevention after systemic embolism in patients with rheumatic 
mitral valve disease, mitral valve prolapse, mitral annular calcification, non rheumatic 
mitral regurgitation, aortic plaques larger than 4 mm.
2
 
          However, one of the major drawbacks in the use of oral anticoagulant and anti 
platelet therapy is the increased risk of bleeding after traumatic injuries and surgical 
procedures. Patients receiving OAT are generally older, present with multiple 
comorbidities, and receive several medications.
3
 
The agents most commonly used to control and prevent thromboembolic 
events are thrombocyte aggregation inhibitors (such as acetylsalicylic acid (ASA) and 
clopidogrel) and vitamin K antagonists (such as warfarin, acenocoumarol, and 
fenprocoumon)
4
. 
ANTIPLATELET THERAPY AND ORAL SURGERY: Since platelets 
provide the initial haemostatic plug at the site of a vascular injury, they are involved 
in pathological processes and are an important contributor to arterial thrombosis 
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leading to myocardial infarction and ischemic stroke
5
. The common anti platelet drugs 
are ASA, clopidogrel and dipyridamole. 
When platelets are inhibited, it takes longer time for free blood flow from a 
cut to stop and for primary haemostasis to occur, as a consequence, the bleeding time 
is prolonged
6
. However, the effect on primary haemostasis is minimal in patients 
without additional risk factors for impaired clotting. Anti platelet medications can 
double the baseline bleeding time, but this may still be within or just outside the 
normal range. It has been reported that only 20% to 25% of patients using ASA have 
an abnormal bleeding time
6
.  
Patients taking anti platelet medications will have a prolonged bleeding time, 
but this may not be clinically relevant because postoperative bleeding after dental 
procedures can mostly be controlled using local haemostatic measures. 
ANTICOAGULATION THERAPY AND ORAL SURGERY: The goal of 
anticoagulant therapy is to prevent clot formation or expansion and Warfarin is the 
most common drug used in this therapy
7
.  If warfarin therapy is stopped, it would take 
about four days for INR to reach 1.5 in almost all patients and with this INR, any 
surgery can be safely performed.
8
 After warfarin therapy is restarted, approximately 
three days will be needed for the INR to reach 2.0. Therefore, if warfarin is withheld 
for four days before surgery and treatment is restarted as soon as possible after 
surgery, patients would have a sub-therapeutic INR for approximately two days 
before surgery, and two days after surgery increasing the risk of thromboembolism
9
. 
Besides this, the intensity of anti-coagulation, the perioperative risk of 
thromboembolism may be increased due to other factors, in particular a rebound 
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hypercoagulable state caused by the dis-continuation of warfarin and the 
prothrombotic effect of the surgery itself
10
. Consequently, for patients whose INR 
returns to normal shortly after stopping warfarin therapy, it can be assumed that the 
risk of preoperative arterial thromboembolism, postoperative arterial thrombo-
embolism, and preoperative venous thromboembolism will be similar to that which is 
expected in the absence of anticoagulation
11
. 
BLEEDING  VS THROMBOEMBOLIC COMPLICATIONS: Even though 
continuing the antiplatelet or the anticoagulation therapy during dental surgical 
procedures would  increase the risk of postoperative bleeding requiring intervention, 
stopping them does not guarantee that the risk of postoperative bleeding requiring 
intervention will be eliminated as serious bleeding can occur in non-anticoagulated 
patients
12
. Most cases of postoperative bleeding can be managed by pressure or 
repacking and resuturing the sockets. The incidence of postoperative bleeding which 
could not be controlled by local measures varied from 0% to 3.5% .
13
 
Bleeding complications, while inconvenient, do not carry the same risks as 
thromboembolic complications. Patients are at high risk of permanent disability or 
even death if they stop anti platelet or anticoagulation medications prior to an any 
surgical procedure than if they continue it. Thromboembolic events, including 
fatalities, had  been reported after antiplatelet or anticoagulation withdrawal. 
Although the risk is low, the outcome is serious. This must be balanced against the 
fact that there is no single report of uncontrollable bleeding when dental procedures 
had been carried out without stopping anti platelet or anticoagulation medications
14
. 
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It is important to consider the consequences of venous and arterial 
thromboembolism, and of bleeding, in addition to the rates at which these outcomes 
occur. Six percent of recurrent episodes of venous thromboembolism were expected 
to be fatal
15
. A small group of patients with recurrent events, perhaps 2%, will have 
serious permanent disability, though the majority will recover well. The consequences 
of thromboembolism are much more serious; approximately 20 % of these episodes 
could be fatal, and 40 % result in serious permanent disability
16
. 
No cases of permanent disability or death, reported as a consequence of 
postoperative bleeding associated with a dental surgical procedure in which the 
patient continued oral anticoagulation, were found. The majority of researches that 
had considered the risks of stopping versus continuing anti coagulation or anti platelet 
therapy for dental procedures had concluded that most dental patients can undergo 
dental procedures without stopping their therapies provided that local haemostatic 
measures were used to control post operative bleeding
17
. 
The Use Of Topical Tranexamic Acid Mouthrinse To Prevent Postsurgical 
Bleeding: 
 The "traditional methods" of managing dental patients who are on oral anti 
coagulants and anti platelets require tooth extraction have significant 
disadvantages. A safe, effective method was required which causes minimal 
inconvenience to patients in terms of delay in treatment, management 
requirements and number of visits.  
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 A technique that broadly meets these requirements was first described by 
Sindet-Pedersen et al. (1989) and subsequently verified by Ramstrom et al. 
(1993). This technique uses the antifibrinolytic agent, tranexamic acid as a 
mouth rinse to prevent post extraction bleeding. Initially it was used to irrigate 
the wound following extraction and then as a mouthrinse 6 hourly for 7 days. 
Used in this way tranexamic acid syrup acts locally to prevent fibrinolysis of 
the blood clot in the tooth socket and minimise post extraction bleeding.
1
 
 
Aims & Objectives 
6 
 
AIM :      
The aim of this study is to research and observe a sample of 100 patients who 
are on anti coagulant and anti platelet therapy going for teeth removal while being 
maintained at therapeutic INR and using tranexamic acid as mouth rinses post 
operatively to achieve hemostasis. 
OBJECTIVE: 
a) To verify that this technique is a relatively safe, simple, effective and an 
acceptable method of   managing these patients; 
b) To identify risk factors that may have the potential to increase the likelihood 
of bleeding. 
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Forbes et al (1972) conducted a double-blind trial study using tranexamic 
acid 1 g three times a day for five days, and he noticed significantly reduced blood 
loss and transfusion requirements after dental extraction in patients with hemophilia 
and Christmas disease. No side effects were seen. Screening tests showed no toxic 
action of tranexamic acid on the liver, kidney, or heart.
18
 
Sindet-Peterson & Stenbjerg (1986)   evaluated 3 groups of patients (56 
subjects) all with congenital deficiencies in factor VIII and factor IX.  Group 1 
received high doses of factor concentrate and systemic TXA. Group 2 received the 
same therapy as the 1
st
 group with an addition of topical mouth-rinse Tranexamic 
acid. Group 3 received factor replacement therapy to increase levels to approximately 
10 % of the normal value perioperatively, combined with systemic and local 
Tranexamic acid mouthrinse.  The author concluded that local anti fibrinolytic therapy 
as a supplement to systemic therapy which significantly decreased the incidence of 
postoperative bleeding. Atlast, the study results suggested that replacement therapy of 
deficient clotting factors may be reduced during oral surgery in hemophilia patients 
with utilization of fibrinolysis inhibitors.
19 
Ramstorm et al (1993) reported the hemostatic effect of tranexamic acid 
solution (4.8%) used as a mouthwash was compared with a placebo solution in 93 
patients on continuous, unchanged, oral anticoagulant treatment undergoing oral 
surgery. Before suturing, the surgically treated region was irrigated with 10 ml of 
tranexamic acid (46 patients) or placebo (47 patients) solution. The patients then 
performed mouthwash with 10 ml of the solution for 2 minutes four times daily for 7 
days. The treatment groups were comparable regarding age, smoking habits, and 
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surgery. No significant difference in the range at which surgery was performed was 
found between clinics. In the placebo group, 10 patients developed bleeding. The 
treatment with mouthwash was well tolerated. It was concluded that patients on oral 
anticoagulants can undergo oral surgery within the therapeutic range without reducing 
the dosage of anticoagulants, provided that local antifibrinolytic treatment with 
tranexamic acid solution is instituted.
1
 
Borea et al. (1993) reported 15 of the study group used tranexamic acid mouth 
rinse postoperatively and maintained oral anticoagulation and anti platelet therapy at 
therapeutic levels while the control group reduced their level of oral anticoagulation. 
There was no significant difference between the 2 groups in the incidence of bleeding 
after oral surgery. From this the author concluded that OAT does not need to be 
withdrawn before any oral surgery provided that local antifibrinolytic therapy was 
instituted.
20
 
Souto et al. (1996) reported that they had carried out oral surgery on over 100 
patients who had maintained the level of their oral anticoagulants and used tranexamic 
acid mouth rinses post operatively. There was no major bleeding complications.
21
 
  Bandrowsky et al. (1996) reported the case of a patient with a pre-extraction 
INR of 3.5 who had 20 teeth removed. On the 4
th
 day after tooth removal, the patient 
who bleed and required hospital admission, had an INR that had risen to 9. The bleed 
was thought to be due to the grossly elevated INR that had occurred from the 
interaction of warfarin with amoxycillin. This adverse event cannot be construe as a 
primary failure of tranexamic acid related inhibition of fibrinolysis.
22
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  Gaspar et al. (1997) evaluated 47 patients receiving anticoagulant therapy. 15 
members in control group had their surgery carried out after oral anticoagulant and 
anti platelet medication was reduced. The 32 patients in test group underwent surgery 
without a change in anticoagulant therapy but used tranexamic acid mouth rinse 
postoperatively. There was no significant difference in the incidence of bleeding 
between the 2 groups. 
   Herman et al. (1997) wrote, "In certain situations, primarily those dealing 
with complex oral surgical procedures, were not sufficient reports to make 
generalization about patient treatment. There is a clear need for focused research in 
this area. It is inappropriate to group all types of dental treatment into a single 
category". 
24
 
     Although Purcell (1997) discussed the management of the anticoagulated 
patient and described the use of tranexamic acid, and he identifies the potential risk 
factors that may increase the likelihood of bleeding in this group of patients so they 
are better managed.
25
 
Kearon and Hirsh (1997) quantified the risk of thromboembolism in various 
situations. After an acute episode of venous thromboembolism, the risk of recurrence 
declines rapidly over the following 3 months. In the absence of anticoagulation the 
risk of recurrence of venous thromboembolism in the 3 months after proximal deep 
vein thrombosis is approximately 50%. On this basis, it is estimated that stopping an 
antiplatelet and anticoagulation in the first month after an acute thromboembolic 
event is associated with a very high risk of recurrent venous thromboembolism (40% 
in a 1-month interval). In the second or third month after an acute event, the risk of 
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thromboembolism becomes intermediate (10% in a 2 month interval) if anticoagulants 
and anti platelets are stopped.  Author estimated that anticoagulation reduced the risk 
of recurrent venous thromboembolism by about 80%. A patient with non-valvular 
atrial fibrillation, not on antithrombotic therapy had an average risk of systemic 
embolism of 4.5% per year. In this situation, anticoagulation and anti platelets reduces 
the risk of embolism by 66%. It is estimated that the risk of major thromboembolism 
in patients with mechanical heart valves was 8 % per year. Anticoagulation reduced 
this risk by 75%. Anticoagulant and anti platelet are therefore highly effective at 
preventing recurrent
26
 thromboembolic events in patients receiving this medication 
for venous and arterial diseases.
18
 
Wahl (1998) carried out a review of the available literature on dental surgery 
in anticoagulated patients. He viewed 26 case reports on 774 patients who underwent 
nearly 2014 invasive dental surgical procedures, including 1964 extractions while 
receiving continual oral anticoagulant therapy. He observed that although some 
patients had minor oozing managed with local measures, more than 98% of patients 
received continuation of anticoagulation had no serious bleeding problems after dental 
surgery. Only 12 patients (<2%) had bleeding problems that required more than local 
measures.
27
 
Wahl (1998) in his second review of 16 case reports from 493 patients 
involving 542 procedures was carried out on patients who had continual 
anticoagulation withdrawn specifically for dental procedures. Five patients (1%) had 
serious embolic complications, including 4 deaths
27
. 
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  Devani et al. (1998) removed teeth in 65 patients on oral anticoagulants. The 
32 members who formed the control group had their warfarin reduced for 2 or 3 days 
while the 33 members of the study group had their INR maintained at therapeutic 
levels. No immediate postoperative bleeding were reported in either group and only 1 
patient from each group had mild delayed haemorrhage. This was easily controlled by 
local measures. There had only been 1 report of a major bleed following this 
protocol
28.
  
 Bernardoni saccarro et al (1998) did a study in Thirty seven dental 
treatments were performed in 15 patients. Group A: nineteen extractions, treated with 
oral rinse with tranexamic acid (250 mg dissolved in 10 ml of water). Group B: 
eighteen extractions, in which oral rinse was utilized. Only in five (13.5%) dental 
extractions (1 from group A and 4 from B) bleeding prolonged were observed. The 
results suggested that mouth washing with tranexamic acid prevents excessive oral 
bleeding in patients treated with oral anticoagulants with an INR between 1.7 and 
2.5.
29
 
Blinder et al (1999) reviewed the postoperative bleeding in patients with oral 
anticoagulant treatment those who were underwent dental extractions without 
discontinuation of the treatment and he compared the effect of 3 different hemostatic 
modalities in 150 patients underwent dental extractions were divided into 3 groups. 
Local haemostasis were carried out as follows: group one (119 extractions), with 
gelatin sponge and closure with sutures; group two (117 extractions), with gelatin 
sponge and sutures, and mouth rinse with tranexamic acid; group three (123 
extractions), with fibrin glue, gelatin sponge, and closure with  sutures.
30 
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Fordyce and Bailey (1999) commented, "What is needed now is a study with 
large numbers of patients, including adequate numbers with an INR greater than 3.0 
before it can be stated with confidence that adjustment to the dose of anti coagulant/ 
anti platelet was unnecessary provided that the INR is within the therapeutic range.
31 
  Ardekian et al (2000) investigated a study regarding stopping versus 
continuing low-dose ASA prior to dental extraction. 30 patients taking ASA 100mg 
daily were studied. Nineteen continued ASA as normal, while 20 stopped taking ASA 
seven days before the planned extractions. A bleeding time test was performed one 
hour prior to the procedure. The mean bleeding time was longer in patients who 
continued ASA compared to those who stopped. Although the difference was 
statistically significant, none of the patients who continued ASA had a bleeding time 
outside the normal range in this study (2-10 min). Intraoperative bleeding was 
controlled in 33 (85%) patients with gauze packing and sutures. Six patients (2 who 
stopped ASA and 4 who continued ASA) had tranexamic acid added to the local 
packing. At the end of the study, it was observed that no patient experienced 
uncontrolled bleeding immediately after the procedure or in the following week.
32
       
    In another study, Wahl (2000) also estimated the incidence of serious bleeding 
problems in 950 patients receiving anticoagulation therapy undergoing 2400 
individual dental procedures. Only 12 patients experienced bleeding uncontrolled by 
local measures and none of the patients were reported to have experienced serious 
harm. Of these 12 patients, seven had higher than recommended anticoagulation 
levels; three were given a course of postoperative antibiotics, which may interacted 
with the warfarin and two were using a placebo mouthwash four times a day 
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immediately after the procedure, which is contrary to standard advice to avoid rinsing 
for the first 24 h.
33 
Campbell et al. (2000) randomized 25 patients to discontinue warfarin 72-
96 hours prior to surgery (13 patients) or to continue ant icoagulants (12 
patients). A further group of ten individuals not receiving anticoagulants served 
to establish a baseline bleeding risk. No patient in any group had postoperative 
bleeding `sufficiently severe to require therapeutic intervention and there were no 
significant differences in blood loss between the three groups.
34 
 Blinder et al (2001) reviewed the incidence of postoperative bleeding in 
patients treated with oral anticoagulant therapy those who underwent dental 
extractions without interruption of anticoagulant treatment to analyze the incidence of 
postoperative bleeding according to the (INR) value. The 249 patients who underwent 
543 dental extractions were divided into five groups. Of the 249 patients, thirty 
presented with postoperative bleeding (12%): Group one, 3 patients presented with 
bleeding (5%), Group two , 10 patients (12.8%), Group three , 9 patients (15.2%), 
Group four ,5 patients (16.6%) and Group five, 3  patients (13%).
18 
The incidence of 
postoperative bleeding were not significantly different among the 5 groups. The value 
of the INR at the therapeutic dose does not significantly influence the incidence of 
postoperative bleeding. Therefore, dental extraction can be performed without 
interruption of oral anticoagulant and antiplatelet treatment. Local haemostasis with 
gelatin sponge and silk sutures appears to be sufficient to prevent postoperative 
extraction bleeding.
35
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Evans et al (2002) reviewed 109 patients on continuous OAC requiring 
dental extractions to either continue (57 patients) although if the INR was less 
than 4 on the day of surgery, the patient was stopped. The control group (52 
patients) stopped taking OAT two days prior to surgery and if the INR was 
greater than 2 on the day of the procedure this was subsequently rebooked for the 
following day. From this study the author concluded that the rate of bleeding was 
higher in the group continuing anticoagulation than in control group but the 
difference between the two group was not significant.
36 
Lockhart et al (2003) reviewed that postoperative bleeding was considered to 
be a significant if it conforms to the following four criteria: the bleeding continues 
beyond 12 hours; it causes the patient to call or return to the dental department or 
emergency department; results in the development of a large haematoma or 
ecchymosis within the soft tissues; and requires a blood transfusion.
37
 
Carter et al (2003) evaluated the use of a prescribed 4.8% TXA post-
operative mouthwash over 2days vs 5 days to prevent bleeding in patients taking anti 
coagulant who requires dental extractions. Eighty five patients under anticoagulant 
therapy who requires dental extractions, were randomly divided into 2 groups. Group 
A postoperatively received a 4.8% TXA mouthwash to be used over 2-day period. 
Group B received the same TXA mouthwash and postoperatively instructed, to be 
taken over 5 days. 82 of the 85 patients had no postoperative problems. 2 patients in 
group A and 1 in group B had minor postoperative bleeds that required minor 
intervention to control. This study shows that a 2-day postoperative regime of a 4.8% 
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tranexamic acid mouthwash was as equally effective as a 5-day regime in controlling 
post extraction bleeding.
38
 
Cannon and Dharmar (2003) suggested Growing evidence that anticoagulant 
treatment does not need to be withdrawn or reduced before oral surgery, as long as 
local hemostatic measures including suture and irrigation of surgical site with TXA 
followed by mouthwash were performed for these patients. Other hemostatic agents 
such as autologous fibrin sealant, absorbable gelatin sponges, and oxidized cellulose 
polymer had also been indicated in surgical practice.
39
 
Keiani Motlagh et al (2003)  did  prospective clinical study on use 
of tranexamic acid mouthwashes in patients taking oral anticoagulants underwent 
minor oral surgery, without modifying their anticoagulant therapy and he did study on 
Forty patients (18 men and 22 females) aged from 42 to 81. All patients were under 
the same anticoagulant, vitamin K antagonist, (Sintrom) for different pathologies. The 
anticoagulant therapy was modified neither before nor after surgery. Tranexamic 
acid 5% (Exacyl) mouthwashes were prescribed during and after surgery and no 
postoperative bleeding was reported.  So he stated that Use of tranexamic 
acid mouthwashes under a specific protocol was an efficient, reliable and economic 
method in preventing postoperative bleeding in patients under oral anticoagulant 
therapy.
40
 
R. Sacco MD, M. Sacco MD, (2007) reported that One hundred thirty-one 
patients on OAT were randomized to reduced anticoagulation or to full 
anticoagulation, and 511 teeth were extracted by the same surgeon. Mild bleeding, but 
excessive enough to warrant adoption of supplementary local hemostatic measures, 
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were observed in 10 cases (15.1%) in the reduced dosage group and in 6 cases (9.2%) 
in the unmodified dosage group, which was a non significant difference. There were 
no thrombotic complications in either group and he concluded this randomized study 
showed that, using simple measures for local hemostasis it is not necessary to reduce 
OAT in patients undergoing routine dental extractions.
41
 
Aframian et al. (2007) concluded that patients administered low-dose ASA 
can undergo any type of oral treatment, minor surgery and/or tooth extractions, 
without having to suspend the antiplatelet medication, and without any added risk for 
the patients with help of local hemostatic measures being more than enough to secure 
bleeding control
42.
 
Pototski et al (2007) reviewed that antiplatelet and anticoagulant agents had 
been extensively researched and developed as potential therapies in the prevention 
and management of arterial and venous thrombosis. On contrary, anti platelet and 
anticoagulant drugs were also been associated with an increase in bleeding time and 
risk of postoperative hemorrhage and he concluded that the optimal INR value for 
dental surgical procedures is 2.5 because it minimizes the risk of either hemorrhage or 
thromboembolism so minor oral surgical procedures, such as biopsies, dental 
extraction and periodontal surgery, can safely be done with an INR lower than 4.0.
43
 
Madrid and sanz (2009) reviewed nineteen studies were identified reporting 
outcomes after oral surgery procedures. Five studies were randomized-controlled 
trials, 11 were controlled clinical trials and three were prospective case series. The 
results of these studies are very homogeneous, reporting minor bleeding in very few 
patients, without a significant difference between the OAT patients who continue with 
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the vitamin K antagonists vs. the patients who stopped this medication before surgery. 
These post-operative bleeding events were controlled only with local haemostatic 
measures: tranexamic acid mouthwashes, gelatin sponges and cellulose gauzes  
application were effective. In none of the studies was a thromboembolic event 
reported and they concluded OAT patients those are continue the AC medication does 
not have a significantly higher risk of post-operative bleeding than non-OAT patients 
and they also do not have a higher risk of post-operative bleeding than OAT patients 
who discontinue the medication. In patients with OAT (INR 2-4) without 
discontinuation, topical haemostatic agents were effective in preventing post-
operative bleeding.
44 
Nematullah et al (2009) reported that his recent meta-analysis showed that 
peri operative continuation of warfarin did not increase the risk of bleeding for 
patients undergoing minor dental procedures.
45 
       Soma et al in 2010 reviewed dental surgical extractions that were performed on 
532 patients diagnosed at risk of thromboembolism without interrupting their 
anticoagulant therapy. And he confirmed that anticoagulant therapy can be modified 
successfully and no need to be interrupted, which can carry significant risks.
46 
 Manuel-Alejandro et al (2010) compiled a sample of 1194 patients selected. 
Of these patients, a total of 2392 simple, serial surgical extractions were performed; 
none of the patients interrupted their anticoagulant treatment with warfarin sodium. 
Of these eighty three sample presented with a some degree of bleeding; where in 
seventy seven of samples, the bleeding was controlled with local hemostatic 
measures, where in six patients required their dose of OAT to be adjusted. There was 
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a higher incidence of post extraction bleeding in patients with periodontal pathology, 
compared to caries and pericoronitis and the author concluded that there was an 
increased number of bleeding in patients with periodontal problems, due to the 
increased presence of inflammation in the soft tissues. 
47
 
 Campell et al (2010) suggested that many patients can undergo surgical 
treatments safely without interrupting their usual therapeutic anti-coagulation regime 
and without any additional medical intervention by using TXA locally as a post-
operative antifibrinolytic agent for 2 days
48
. 
 Christian Bacci et al (2010) et al conducted Four hundred fifty-one patients 
being treated with warfarin who required dental extraction were compared with a 
control group of 449 non-anticoagulated subjects undergoing the same procedure. In 
the warfarin-treated group, the OAT regimen was maintained unchanged, such that 
the patients had an INR ranging between 1.8 and 4, and local haemostatic measures 
(i.e. gauzes saturated with tranexamic acid) were adopted. Of these 2 groups report 
was not statistically significant. And he stated that results of this study which applied 
in large, multicenter study show that dental extractions can be performed easily and 
safely in an OAT outpatients without any interruption of the ongoing oral 
anticoagulant therapy, thus minimizing the costs and reducing discomfort for 
patients.
49 
Ker et al (2013) reviewed 29 trials involving 2612 participants. In this study 
28 trials involved   patients undergoing surgery  without bleeding and only one trial 
involved patients with epistaxis (nosebleed). Thus Tranexamic acid  reduced blood 
loss by 29%  There was uncertainty regarding the effect on death myocardial 
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infarction , deep vein thrombosis and pulmonary embolism TXA reduced the risk of 
receiving a blood transfusion by a relatively  45%. By this the author concluded that 
topical application of tranexamic acid reduces bleeding and avoid blood transfusion in 
surgical patients, however the effect on the risk of thromboembolic events was 
uncertain.
50 
Sammar tino et al. ( 2012) stated that  cardiovascular disease was the most 
common cause of mortality in elderly people worldwide, oral anticoagulants are 
widely used for long-term prevention or treatment of cardiovascular events, including 
stroke and myocardial infarction. For this reason, the management of patients on OAT 
requiring surgical procedures remains a challenge due to the risk bleeding if therapy 
was continued.
51 
Wardrop et al. (2013) stated the literature with regard to the use of 
antifibrinolytics for the prevention of post extraction bleeding in patients with 
hematologic disorders. The author suggested that TXA and ACA may be useful 
adjuncts to platelet transfusions so that platelet use, and their complications associated 
with their use, can be reduced. However, the sample of this study were too small to 
assess whether antifibrinolytics which  increased the risk of thrombo embolic 
events.
52 
Gandhi et al (2013) reported that TXA, a synthetic derivative of the amino 
acid lysine, was an antifibrinolytic agent that blocks lysine-binding sites on 
plasminogen, thereby reducing the local degradation of fibrin by plasmin. TXA works 
to stabilized and to inhibit the degradation of existing clots, and it was widely used to 
limit bleeding in clinical practice. A series of systematic reviews and meta-analyses 
Review of Literature 
  20 
 
were published showing strong evidence that TXA is effective in reducing blood loss 
and transfusion requirements in knee arthrosplasty.
53 
Micheal Wahl (2014) stated that the physicians and dentists must weigh the 
bleeding risks in continuing antiplatelet medications versus the thrombotic risks in 
interrupting antiplatelet medications. However, the risk for thromboembolic 
complications after interruption of antiplatelet and anti coagulant therapy for dental 
procedures was apparently significant, although small.” Thus there was a small 
chance that continuing antiplatelet therapy that will result in  non fatal bleeding which 
requiring local measures for hemostasis versus a small but significant chance that 
interrupting antiplatelet therapy will result in a possibly fatal thromboembolic 
complication. So the author stated that the decision was simple: “It is time to stop 
interrupting antiplatelet and anticoagulant therapy for dental surgical procedures.
54 
Ripolles de ramon J (2014) et al. Hypothesis was based on studies of local 
application of tranexamic acid after maxillofacial interventions as effective 
therapeutic alternative for the prevention and control of bleeding.  With this the author 
stated that the effectiveness of the application of a tranexamic acid solution after tooth 
extraction in anticoagulated patients in terms of healing time and degree of healing.
55 
Kammerer et al (2015) reviewed the clinical protocol to reduce the risk of 
bleeding during surgery or invasive procedures in patients receiving OAT remains 
controversial. Different recommendations has been proposed, including reduction, 
complete withdrawal, or substitution of OAT with heparin prior to the surgical 
procedure, but there was strong evidence that OAT patients undergoing oral surgeries 
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should not discontinue their medication due to the risk of thromboembolic 
complications.
56 
Wei and Liu (2015) did a series of Systematic reviews and meta-analyses 
were published showing Strong evidence that TXA was effective in reducing blood 
loss and Transfusion requirements in knee arthroplasty , hip surgeries, and spinal 
surgeries without increased. Thromboembolic complications such as myocardial 
infarction, deep venous thrombosis, and pulmonary embolism.
57 
Lucy et al (2016) investigated the incidence of bleeding after dental extraction 
without stopping antiplatelet therapy. Postoperative bleeding was assessed in a total of 
1271 patients who were divided into 2 groups: a study group comprising 183 patients 
on antiplatelet therapy who underwent 548 dental extractions on 274 occasions and a 
control group comprising 1088 patients who were not receiving any antiplatelet or 
anticoagulant therapy and underwent 2487 dental extractions on 1472 occasions. 
However, the differences were not significant. Postoperative bleeding were managed 
successfully by repacked with Gelfoam impregnated with tranexamic acid powder in 
12 patients and by resuturing in three of the control patients undergoing extraction of 
impacted teeth with flap elevation. Finally author concluded that there was no need to 
interrupt antiplatelet drugs before dental extraction.
58 
Quireoz et al (2016) reviewed the increased risk of bleeding observed in 
patients on oral anticoagulant therapy (OAT) undergoing outpatient oral surgical 
procedures had been reported in the literature and remains a major concern in the care 
of these patients. This is still of great concern to dental surgeons that discontinuing 
OAT medication increases the risk of thromboembolism, while maintaining the 
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therapeutic dose increases the risk of hemorrhage. The author represented 1821 
patients receiving OAT, 4116 tooth extractions, and 144 cases of postoperative 
bleeding. In most studies, there were no differences in the effectiveness of various 
local hemostatic measures, and only tranexamic acid was proven effective as 
compared with a placebo group. The reported INR values varied widely among 
studies; the lowest INR value was 0.9 and the highest was 5.0. All local hemostatic 
methods showed low rates of bleeding; and when bleeding occurred, the use of these 
methods was essential for controlling postoperative bleeding. While local hemostatic 
measures appear to be effective in controlling postoperative bleeding, additional 
controlled randomized clinical trials were needed to assess the true effectiveness of 
these measures in patients taking OAT.
59 
Murphy et al (2016) stated that the antifibrinolytic drug tranexamic acid 
(TXA) was effective in reducing blood loss and transfusion requirements in other 
fields of elective surgery and its use was emerging in a number of plastic surgical 
subspecialties. This systematic review and meta-analysis evaluated the current 
evidence for the efficacy and safety of TXA in craniomaxillofacial, head and neck, 
breast, aesthetic, burns, and reconstructive microsurgery. Studies were analyzed using 
standard methodology. A total of 7965 records were screened, of which 14 met the 
inclusion criteria. Seven were suitable for meta-analysis. In craniofacial surgery, TXA 
was associated with a mean reduction in blood loss of 18.2 mL/kg (P = 0.00001) and a 
mean reduction in blood transfusion of 8.7 mL/kg (P = 0.0001). In orthognathic 
surgery, TXA was associated with a mean reduction in blood loss of 156 mL (P = 
0.001). Tranexamic acid may also have a role in reducing drainage output volumes in 
oncological breast excision and lymph node dissection of the neck. Level-1 evidence 
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for efficacy in aesthetic surgery, burns, and reconstructive microsurgery is lacking. 
Although no reported complications were attributable to TXA, there remain no phase 
IV trials published. Level-1 evidence supports the use of TXA in craniofacial and 
orthognathic surgery. There exists an unmet need for studies in areas, including burns, 
aesthetic surgery, and reconstructive microsurgery. Phase IV trials in areas of proven 
efficacy are also required.
60 
Ali Mithiborwala et al (2016) evaluated the post extraction control of 
haemorrhage with administration of TXA as pressure pack in patients on 
anticoagulant and antiplatelet therapy. And he reported no instances of post extraction 
bleeding, except in 1 and whom intravenous TXA was given, which the bleeding was 
controlled. No TXA allergy was noted. And postoperative control of haemorrhage 
was there acceptable in all the cases. 
61 
Sara Juliana et al (2017) suggested that surgical site irrigation with TXA 
followed by mouthwash during the first postoperative week is safe and may reduce 
the risk of bleeding after minor oral surgeries in anticoagulated patients. However, 
additional trials should be conducted to compare TXA efficacy over absorbable 
hemostatic materials.
62 
   Nishidha et al (2017) summarized the recent evidence or recommendations in 
the related guidelines related TXA and briefly summarized the evidence for the safety 
of TXA administration by a systematic review method using observational studies. 
Consequently, the relative risk for venous thromboembolism was 1.61, indicating a 
non-significant increase in the venous thromboembolism risk of TXA therapy. 
63
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A. Study design: Comparative interventional study 
B. Study participants (human) 
a. Inclusion criteria 
 Who were on oral anticoagulants and anti platelets and required 
removal of teeth; 
 With an INR between 1.9 and 3.5 on the day of surgery 
 Aged 18 years or older 
b. Exclusion criteria 
 They failed to give informed consent; 
 They had a known bleeding disorder or liver failure; 
 They had an INR less than 1.9 or an INR greater than 3.5; 
 Patients who are on dual anti platelets, dual anti coagulants, 
antiplatelet and anti coagulant. They had an APTT greater than 55 
seconds or a bleeding time greater than 8 minutes, unless cleared 
by advice from a haematologist; 
 They were unable to follow instructions, either because of 
language difficulties or because of intellectual or physical 
impairment. 
c. Number of groups to be studied, identify groups with definition  : 1 
Group  
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C. Sampling  
a. Sampling population : 100 
b. Sample size calculation  
𝑵 =
𝟒𝒑𝒒
𝒅𝟐
 
 P=incidence of bleeding =42.86
(64)
. 
Q=100-P   D=20% of P 
Sample size = 100 
Total sample size of study = 100 
c. Sampling technique : Convenient  sampling 
STUDY PROCEDURE:  
The patients were managed at Department of Oral and Maxillofacial Surgery 
OPD in Sree Moookambika Institute of Dental Sciences. Prior to the surgery the 
patients concerns were discussed. Their general medical conditions were assessed and 
the proposed treatment plan confirmed. The patients BT, INR and APTT were 
recorded. If the INR is in the range 1.9 – 3.5 the patient was admitted to the study. If 
the INR below 1.9 the patient was managed conventionally using local measures 
without entering the study and without using tranexamic acid mouthrinse. If the INR 
value was greater than 3.5 they were excluded from the study. Patients with cardiac 
condition requiring prophylactic antibiotic cover were given oral / intravenous 
antibiotics according to American Heart Foundation Guidelines. 
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Uncomplicated extraction was carried out under local anaesthetic in the dental 
chair using 2% lignocaine with 1:80,000. The teeth were removed using either forceps 
and /or elevators. Following delivery of the tooth, the wound was thoroughly irrigated 
with 10% tranexamic acid solution, care being taken not to suck this out of the socket. 
The socket wall was compressed using finger pressure over a swab soaked in tranexamic 
acid solution. The wound was then closed using 3 '0' black silk suture. After the 
completion of surgery, the patient was asked to bite on a pressure pad soaked in 
tranexamic acid solution. After 10 minutes the pack was removed and the wound was 
observed. If the bleeding had stopped the patient was  discharged with their home-care 
pack of tranexamic acid mouthrinse and post-operative instructions.
 
If bleeding had not stopped, the point of bleeding was identified and gelatin 
sponge was placed into the wound at this point. The patient was then asked to bite on 
a pressure pad soaked in tranexamic acid solution. After 10 minutes the pack was 
removed and the wound was observed. If bleeding had stopped the patient were 
discharged and was provided with their home-care pack of tranexamic acid 
mouthrinse along with post-operative instructions. 
If the bleeding had not stopped, the point of bleeding was identified. The 
sutures at that point were removed and the local area around the bleeding site was 
infiltrated with local anaesthetic solution. The wound was then irrigated with 10 % 
tranexamic acid mouthrinse and oxidised regenerated cellulose and / or gelatin sponge 
soaked in bovine thrombin solution inserted into the base of the oozing socket. The 
socket was sutured with silk sutures and the patient asked to bite on a pressure pad 
soaked in tranexamic acid solution. After 20 minutes the pack was removed and the 
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wound observed. If bleeding had stopped the patient was discharged along with their 
home-care pack of tranexamic acid mouthrinse and post-operative instructions.
 
If the patient continues to bleed, this was recorded. Consideration was given to 
an infusion of fresh frozen plasma/ platelets or vitamin K, DDAVP
 
All details of this management and outcome were recorded. 
The patient was discharged with the following items: 
a) 500 mg , tranexamic acid tablets  plus 5 ml measure; 
b) Post-operative instructions/data collection sheet; 
c) Pressure swabs; 
d) Laboratory request form for post-extraction INR on day 4; 
e) Postextraction antibiotics (if required). 
Post- operative instructions:  The patient was instructed to crush the 500 mg 
tablets and dissolved in 5ml sterile water   and use 5ml of tranexamic acid solution as 
a mouth rinse 4 times a day, ie, on waking in the morning, at midday, at 6 o'clock in 
the evening and just before going to bed in the evening. The solution was taken into 
the mouth and gently rinsed over the site of surgery for a minimum of 2 minutes by 
the clock. The solution was then spat out. The patient recorded the time this mouth 
rinse was carried out on the data-collection sheet. Apart from using the tranexamic 
acid mouth rinse, the patients were instructed not to rinse their mouth on the day of 
surgery. Only soft food was to be eaten during first 2days following surgery. On the 
fourth day after surgery the patients was instructed to go to their nearest blood 
collection service for INR testing. If bleeding occurred the patient was instructed to 
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identify the point of bleeding, make a gauze ball, place it over the bleeding socket and 
firmly bite on it for 20 minutes by the clock before removing the pressure packs. This 
incident was recorded on the patient data collection sheet. If after 20 minutes the 
bleeding had not been controlled by pressure then the patient is instructed to contact 
the researcher who would manage the bleed at dental surgery department.
 
Management of postextraction bleeding: 
Any patient presenting to the researcher's dental surgery with post extraction 
bleeding was asked to bring in their tranexamic acid mouthrinse and their data 
collection sheet. The patient was seated in a dental chair and any excess blood clot in 
the mouth was removed. The bleeding point was identified. Local anaesthetic was 
administered to this area. A gauze swab soaked in tranexamic acid solution was 
placed over the bleeding site. The patient was instructed to bite on this. A venous 
blood sample was collected and sent to the hematology laboratory for an INR. The 
history of the presenting bleed was reviewed. The contents of the tranexamic acid 
mouth rinse were measured and the data sheet reviewed to determine the degree of 
compliance to mouth rinse use. After 20 minutes the swab was removed and the 
wound was observed. If the bleeding had stopped the sutures were reviewed and if 
necessary extra sutures placed. If required, gelatin sponge was placed in the wound. A 
gauze swab soaked in tranexamic acid solution was placed over the bleeding site and 
the patient was instructed to bite on this. After 20 minutes the swab was removed and 
the area observed for two minutes. If bleeding had stopped the patient was discharged 
and instructed to continue using the tranexamic acid mouthrinse and avoid 
traumatizing the area. 
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If the wound continued to ooze, the sutures were removed and the bleeding 
point identified gelatin sponge or oxidized regenerated cellulose soaked in topical 
bovine thrombin was applied to the area. The socket was then sutured and pressure 
applied to the area with a pressure pack soaked in tranexamic acid for 20 minutes. The 
swab was then removed and the area observed for 2 minutes. If the bleeding had 
stopped the patient was discharged and instructed to continue using the tranexamic 
acid mouthrinse and avoid traumatizing the area. 
Suture removal appointment 
The suture removal appointment was scheduled on the seventh days after 
surgery. The patient was asked to return the data collection sheet together with the 
tranexamic acid mouth rinse. Once the patients arrival in the department, a quick 
survey was made of the responses on the data collection sheet. The patient was asked 
about their use of the mouth rinse. Any problems or adverse effects associated with 
the mouth rinse were sought out. The sutures were removed and any swelling, 
bruising or limited opening noted. Then the patient was discharged. The data 
collection sheet data was then reviewed in detail. The number of times the mouth 
rinse was used as entered on the sheet by the patient was divided by the number of 
times the mouth rinse should have been used, in order to calculate the percent 
compliance. The data were recorded. 
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DATA COLLECTION: 
On recruitment to the trial the patient was allocated a patient OP and a unique 
serial number under which all data was collected. This ensured that only the 
researcher could identify the patient. All data was confidential. Data was initially 
collected on the clinical data collection sheet before being entered into a computer for 
analysis. This included information on possible factors influencing the initiation of 
bleeding and the management of any rebleeds.  
Demographic details 
Demographic details were collected concerning the patient's age, sex, smoking 
history and their relevant medical history. Details of the patient's medical history were 
gained either by directly from the patient or if required, from the patient's hospital 
notes and/or the patient's general medical practitioner. 
Details about the state of anticoagulation/ antiplatelets: 
The reason for being on anticoagulants and antiplatelets and the length of time 
on anticoagulants / anti platelets was recorded. Immediately prior to surgery the 
patient had their INR, APTT and bleeding time tested.  
Details about the extraction 
The teeth being removed were recorded. 
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Details collected by the patient 
After being discharged from surgery, patients were asked to take home and fill 
in a "data collection sheet" to record the time they used their tranexamic acid mouth 
rinse and record any bleeding that occurred at home. Bleeding was defined as a bleed 
that required that they bite on a pressure swab to control. The mouth was divided into 
6 sites. Top right (maxillary right molars and premolars), top front (maxillary canines 
and incisors), top left (maxillary left molars and premolars), bottom right (bottom 
right molars and premolars), bottom front (mandibular incisors and canines) and 
bottom left (mandibular left molars and premolars). The site of bleeding and the 
length of time the bleed lasted were recorded. The event which caused bleeding was 
recorded as traumatic (if initiated by a specific event) or spontaneous (if not related to 
a specific event). 
Details concerning management of bleeding 
On presentation at the researcher's dental surgery for control of a bleed, the 
patient was asked how and why the bleeding restarted and whether or not the start of 
bleeding was related to a particular event. The site, type of bleeding, presence of local 
infection, oedema or haematoma was noted. The INR was tested and recorded. The 
procedures carried out to achieve haemostasis were recorded. 
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Statistical analysis:  
The data was expressed in number, percentage, mean and standard deviation. 
Statistical Package for Social Sciences (SPSS 16.0) version used for analysis. 
Unpaired and Paired t test applied to find the statistical significant between the 
groups. P values less than 0.05 (p<0.05) considered statistically significant at 95% 
confidence interval. 
Description: 
One hundred individual patients were recruited into this study. There were 
60 males and 40 females. The mean age was 57.1 years with a standard deviation of 
15.6 years (range 23- 87 years). The duration of anti platelet and anti coagulant 
prophylaxis varied between 2 weeks  to  20 years. The median length of therapy was 
2 years. The indications for anticoagulant / anti platelet prophylaxis are shown Table 
5. The majority, (59 %) were smokers. Preoperative antibiotic therapy was involved 
in 12 of the 100 patient contacts for either intercurrent infection or long term 
prophylaxis. The antibiotics used were amoxycillin, penicillin, augmentin and 
cephalosporin. Perioperative antibiotics were prescribed for 62 patient episodes 
(generally for infective endocarditis prophylaxis). Agents used were amoxycillin , 
cephalosporin  and gentamicin . Amoxycillin was necessary to control postoperative 
infection in 75 patient episodes. 
Of these 100 patients treated, 17 reported bleeding at home on  day 1 and 3 
patients after day 1 that was controlled only  by tranexamic acid pressure pack. A 
further 9 patients reported to the researcher's dental surgery where bleeding was 
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controlled by local measures using gelatin sponge. No patients required hospital 
admission for systemic management of bleeding. 
Statistical analysis reveals  significant risk factors for postextraction bleeding 
were: those patients on age between  41-60; pre extraction INR equal to greater than 
2.5; smoking.  
Factors not statistically significant for an increased risk of bleeding included: 
The number of teeth removed; pre-extraction bleeding time; time on anti platelets and  
anticoagulation.       
Finally concluded that the post-operative use of tranexamic acid mouthrinses 
in patients who underwent teeth removal at therapeutic INR  levels is a safe, simple, 
effective and acceptable method of reducing postextraction bleeding. 
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Table-1: Distribution of patients based on age 
Age (Years) Number Percentage (%) 
20-40 years  10* (p=0.03) 10.00* 
41-60 years 64 64.00 
61-80 years  36* (p=0.04) 36.00* 
Total 100 100.00 
(*p<0.05 significant compared 41-60 years with others) 
 
Table-2: Distribution of patients based on gender 
Gender Number Percentage (%) 
Male 60 60.00 
Female 40* (p=0.03) 40.00* 
Total 100 100.00 
(*p<0.05 significant compared male with female) 
 
Table-3: Distribution of patients based on smoking 
Smoking  Number Percentage (%) 
Yes 59 59.00 
No 41* (p=0.05) 41.00* 
Total 100 100.00 
(*p<0.05 significant compared yes with no) 
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Table-4: Mean values of blood parameters pre extraction 
Blood parameters MEAN±SD 
INR 2.29±0.35 
Platelet count   2.32±0.24 
Bleeding time 3.54±0.32 
 
Table-5: Distribution of patients based on reason for being on anti-coagulant 
medication 
Reason for being on anti-
coagulant medication 
Number Percentage (%) 
CAD 72* (p=0.01) 72.00* 
RHD 12 12.00 
AVR 1 1.00 
IHD 4 4.00 
Atrial fibrillation 7 7.00 
TVD 1 1.00 
ACHD 1 1.00 
CAD+IHD 1 1.00 
CHD/ASD 1 1.00 
Total 100 100.00 
(*p<0.05 significant CAD with others) 
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Table-6: Distribution of patients based on time on anti-coagulant medication 
Time on anti-coagulant 
medication 
Number Percentage (%) 
Days 2* (p=0.02) 2.00 
Weeks 73 73.00 
Months 19* (p=0.04) 19.00 
Years  6* (p=0.04) 6.00 
Total 100 100.00 
(*p<0.05 significant compared weeks with others) 
 
Table-7: Distribution of patients based on post extraction bleeding 
Post extraction bleeding Number Percentage (%) 
Yes 28 28.00 
No 72* (p=0.03) 72.00 
Total 100 100.00 
(*p<0.05 significant compared yes with no) 
 
Table-8: Mean values of blood parameters 
Blood parameters  MEAN±SD 
INR 2.37±0.58 
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Table-9: Distribution of patients based on day of post operative bleeding 
Day of post operative 
bleeding 
Number Percentage (%) 
No 71*(p=0.03) 71.00 
1
st
 day 17
#
 17.00 
2
nd
 day 8 8.00 
3
rd
 day 3 3.00 
4
th
 day 1 1.00 
Total 100 100.00 
(*p<0.05 significant compared no with others,  
#
p<0.05 significant compare Nil with others) 
 
Table-10: Distribution of patients based on event which caused bleeding 
Event which caused 
bleeding 
Number Percentage (%) 
No 71* (p=0.01) 71.00* 
Spontaneous 26 26.00 
Trauma 3 3.00 
Total 100 100.00 
(*p<0.05 significant compared no with others) 
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Table-11: Distribution of patients based on degree of bleeding 
Degree of bleeding Number Percentage (%) 
No 71* (p=0.01) 71.00 
Slight ooze 24 24.00 
Frank ooze 5 5.00 
Total 100 100.00 
(*p<0.05 significant compared no with others) 
 
Table-12: Distribution of patients based on post operative bleeding and INR 
Degree of bleeding Number Percentage (%) 
No 71*(p=0.01) 71.00 
Present 29 29.00 
Total 100 100.00 
INR (MEAN±SD) 2.91±3.74 
(*p<0.05 significant compared no with others) 
 
Table-13: Distribution of patients based on treatment to achieve hemostasis 
Degree of bleeding Number Percentage (%) 
No 71*(p=0.01) 71.00 
Pressure 20 20.00 
Hemostat  9 9.00 
Total 100 100.00 
(*p<0.05 significant compared no with others) 
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Table-14: Comparison of pre and post operative INR 
Status  INR (MEAN±SD) P value 
Pre operative  2.29±0.35 0.89 
Post operative  2.37±0.58 
(p>0.05 no significant difference compared pre operative with post operative) 
 
Table-15: Distribution of patients based on frequency of post extraction bleeding 
and its management 
Type of bleed and management Number Percentage 
(%) 
No bleeding 71 71.00 
At home on day one, only 17 17.00 
At home, after day one with pressure 3 3.00 
At researcher's dental surgery with local 
treatment 
9 9.00 
At hospital by systemic treatment 0 0.00 
Total 100 100.00 
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Graph-1: Distribution of patients based on age 
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Graph-3: Distribution of patients based on smoking 
 
 
 
Graph-4: Distribution of patients based on reason for being on anti-coagulant 
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Graph-5: Distribution of patients based on time on anti-coagulant medication 
 
 
 
Graph-6: Distribution of patients based on post extraction bleeding 
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Graph-7: Distribution of patients based on day of post operative bleeding 
 
 
 
Graph-8: Distribution of patients based on event which caused bleeding 
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Graph-9: Distribution of patients based on degree of bleeding 
 
 
 
 
Graph-10: Distribution of patients based on  post operative bleeding and INR 
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Graph-11: Distribution of patients based on treatment to achieve hemostasis 
 
 
 
Graph-12: Comparison of pre and post operative INR 
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Graph-13: Distribution of patients based on frequency of post extraction 
bleeding and its management 
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Tranexamic acid, (trans-4-aminomethylcyclohexanecarboxylic acid, AMCA) 
is an antifibrinolytic drug whose mode of action depends on binding to the lysine-
binding sites of plasminogen thus blocking the binding of plasminogen to fibrin in a 
manner similar to histidine-rich glycoprotein.  
Sindet-Pedersen (1987) found that after systemic administration of 1 gram 
tranexamic acid taken orally, the mean plasma concentration of tranexamic acid 
reached its maximum after 120 minutes at approximately 7ug/ml. However, it is 
important to note that systemic tranexamic acid was not redistributed to saliva at 
detectable levels. After a mouthrinse with 10 ml of 5% aqueous tranexamic acid 
solution for 2 minutes, there was minimal systemic absorption as plasma 
concentrations remained below 2 ug/ml. The concentrations of tranexamic acid in 
saliva were initially very high (after 30 minutes the mean concentration was above 
200ug/ml) decreasing to approximately 7 ug/ml of saliva after 120 minutes and to 
approximately 0.4 ug/ml of saliva after 48 minutes. At a tissue concentration of 10 
ug/ml of tranexamic acid, tissue plasminogen activity is reduced by 80% and by 98% 
at  tissue concentrations of  100 ug/ml.
65
 An inhibition of 80% is considered sufficient 
to suppress fibrinolytic activity in tissue. Thus, tranexamic acid administered topically 
as a mouthrinse remained in saliva at a therapeutic level for more than 2 hours and 
inhibited fibrinolysis. Because there is very little systemic absorption of tranexamic 
acid when it is used as a mouthrinse, systemic side effects of the drug such as nausea, 
diarrhoea and abdominal discomfort are avoided. 
Local haemostasis-promoting materials and techniques are widely used if 
patients have dental extractions with unaltered anti platelet /  anticoagulation.  
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Traditional local methods to reduce post surgical bleeding in anti platelet and anti 
coagulant  patients have included: 
a) Suturing the socket; 
b) Use of a glucosic polymer based sterile knitted fabric prepared by the controlled 
oxidation of regenerated cellulose. Its local haemostatic action depends on the binding 
of haemoglobin to oxycellulose, allowing the dressing to expand into a gelatinous 
mass, which in turn acts both as a scaffold for clot formation and a clot stabilizer. Its 
low pH of 2.8 is also thought to potentiate local vasoconstriction. The material is 
completely absorbable and does not interfere with healing or bone regeneration; 
c) Use of a gelatin based sponge, which is able to hold up to 45 times its weight in 
coagulating blood and acts as a framework until a stable clot has been formed; 
d) Application of topical bovine thrombin is particularly useful in dealing with 
persistent primary haemorrhage. A piece of gelatin sponge is soaked in the 
preparation and packed into the bleeding socket. Thrombin bypasses the coagulation 
cascade by converting endogenous fibrinogen to fibrin; 
e) Use of microfibrillar collagen. 
  Martinowitz (1990)  described various local haemostatic dressings and tissue 
adhesives had been used to control bleeding after dental extractions in anti platelet 
and anti coagulant patients. These include: 
a) A composite biological tissue adhesive, Beriplast (Behringwerke, Marburg, West 
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Germany)  which mimics the final phase of blood clotting. Beriplast contains 
thrombin, which causes fibrinogen to coagulate; factor XIII, as an adjuvant, provides 
for the cross linkage and stabilization of the fibrin clot and aprotinin, an antiprotease 
prevents early disruption of the clot by fibrinolysis.  
b) Fibrin glue and human fibrinogen concentrate. These coagulation protein-based 
dressings induce clot formation by mimicking the final stages in the normal clotting 
mechanism; 
c) Absorbable collagen paste (ACP) and calcium alginatease.
66 
 This study was undertaken to verify that using tranexamic acid mouthrinse 
was a safe, effective and acceptable method of managing anticoagulation and anti 
platelet patients in Sree Mookambika Institute of Dental Science. A novel aspect of 
this investigation was the evaluation of potential risk factors associated with the 
removal of the teeth and the identification risk factors for bleeding. This had not 
previously been reported in this group of patients. It must be recognized that because 
this study did not have a control group it does not provide a high level of evidence 
and does not more than enable the building of a hypothesis about the possible causes 
of post-operative bleeding in anti coagulant and anti platelet patients managed post-
operatively with tranexamic acid mouthrinse. It is important that this limitation was 
borne in mind otherwise it was likely that observed associations could be 
misinterpreted or overstated. In addition, there was an inherent bias in the study 
design because it could not be double blinded. The possibility of information bias by 
both the researcher and patient may had influenced the results. This bias was 
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minimized by collecting data on relevant variables in advance of the bleeding 
endpoint. 
Compliance is an issue in any treatment study. This effect was offset because 
patients on anti platelet and anti coagulant requires a high level of compliance and 
regular monitoring to avoid serious complications. The study population was perhaps 
more motivated to comply. Compliance was assessed by 2 methods. First, the patient 
was asked to record mouth rinse use on the patient data collection sheet. This relied 
on patient honesty not to record when they missed their mouth rinse and carefully to 
record when they did use it. Patients were encouraged to be honest, to only record 
definite mouthrinse use and not enter factitious data. There was also a problem with 
some patients who lived in a rest home. Language and old age were not a barrier to 
compliance as it was possible to recruit either a family member or a friend to take 
responsibility for informing and assisting the patient.  
Ramstrom et al. (1993) reported 4 (8.7%) of 46 patients were not fully 
compliant. Adverse comments about the mouthrinse in their study included were taste 
(3), nausea (1), slight burning feeling (1) and tedious (1). These comments were 
similar to those made in the present study. 
All previous studies have used 10 ml of 4.8% tranexamic acid mouthrinse. 
This study used 5ml of 10% tranexamic acid mouthrinse. The reason for this decision 
was that 10mls of 4.8% tranexamic acid solution contains the same amount of active 
solution as 5mls of 10% solution. The main advantage of the larger volume used in 
other studies is that it may be easier to rinse around the mouth, especially the upper 
jaw. 
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Defining bleeding had its problems. Two levels of bleeding were initially 
considered for analysis. First, bleeding managed either at home after day 1 or in the 
researcher's dental surgery and second, bleeding managed in the researcher's dental 
surgery only. Each of these levels had its advantages and disadvantages. The 
advantage of recording home bleeds after day 1 was that more bleeds were captured 
for endpoint analysis. However, there were several significant disadvantages. This 
relied on the patient accurately reporting and recording any bleeding that occurred at 
home. Different patients had different thresholds for reporting bleeding. This led 
either to under-reporting or to over-reporting depending on the individual patient's 
threshold. In an attempt to standardize home bleed reporting, patients were asked to 
only record bleeding that required a pressure swab to control. Bleeding requiring 
control at home is common following dental extractions, even in patients with normal 
coagulation. When multiple teeth were removed from the same region of the mouth it 
was impossible for the patient to identify and accurately record which tooth socket 
was bleeding. Therefore, when bleeding was recorded in a region by the patient, all 
tooth sockets in that region were recorded as having bleed. By this definition, 26 
sockets were recorded as having bleeding although it was unlikely that all these 
sockets had actually bleed. This may have led to an over-estimation of the incidence 
of home bleeding. For statistical analysis, only "dental surgery bleeds" were used as 
these represented the most objective point. A further advantage of using dental 
surgery-managed bleeds was that the number and position of the bleeding sockets 
could be accurately recorded. A disadvantage of this approach was that relatively few 
endpoint bleeds were available for analysis. There was also variability in the threshold 
at which patients presented themselves to the dental surgery.  
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The major risks associated with removal of teeth in these anticoagulated and 
anti platelet patients were either uncontrolled bleeding or a thromboembolic event. 
Only minor bleeding occurred and this was controlled either at home with pressure or 
in the researcher's dental surgery by local measures. No bleeding required systemic 
therapy or admission to hospital. No thromboembolism occurred. No medical 
emergencies occurred to patients during the  period of the study. Because tranexamic 
acid mouthrinse has minimal systemic absorption (Sindet Pedersen, 1987) and was 
spat out after 2 minutes, it was very safe. If accidentally swallowed it does not have 
any significant adverse effect
63
. The results obtained in this study are consistent with a 
review of the literature by Wahl (1998)
27
. He reported that 98% of 774 patients who 
underwent dental extractions while on anti coagulant / anti platelets patients were 
managed by a number of different techniques had either no bleeding or insignificant 
bleeds that were managed by local measures. Only 12 (2%) cases required 
hospitalization for a short period. It was concluded that this was a safe method of 
managing patients. 
Of these 100 patients treated, 17 reported bleeding at home on day 1 and 3 
patients after day 1 that was controlled only by tranexamic acid pressure pack. A 
further 9 patients reported to the researcher's dental surgery where bleeding was 
controlled by local measures using gelatin sponge. No patients required hospital 
admission for systemic management of bleeding. This bleeding was readily controlled 
after infiltration of the adjacent mucosa with 2% lignocaine solution containing 
1:80,000 adrenaline, removal of the clot, irrigation of the wound with 10% tranexamic 
acid solution, application of pressure with a swab soaked in tranexamic acid solution 
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and gelatin sponge placed in socket and resuturing the socket. No patients required 
hospital admission for systemic management of bleeding. 
Sindet-Pedersen et al. (1989) reported 1 bleed in 19 (5.3%) cases
67
. Ramstrom 
et al. (1993) reported no bleeds requiring treatment in 46 patients
.1
 Borea et al. (1993) 
reported 1 bleed out of 15 (6.7%) requiring treatment
20
. Gaspar et al. (1997) reported 
2 bleeds in 32 patients (6.3%) requiring treatment
23
. Devani et al. (1998) reported 1 
case in 33 (3%) with bleeding requiring treatment
28
. Kearon and Hirsh (1997) 
quantified the risk of thromboembolism A patient with non-valvular atrial fibrillation, 
not on antithrombotic therapy has an average risk of systemic embolism of 4.5% per 
year. In this situation, anticoagulation and anti platelets reduces the risk of embolism 
by 66%. It is estimated that the risk of major thromboembolism in patients with 
mechanical heart valves is 8 % per year. Anticoagulation reduces this risk by 75%. 
Anticoagulant and antiplatelet are therefore highly effective at preventing recurrent.
26
 
Whal (1998) reviewed only 12 patients (<2%) had bleeding problems that 
required more than local measures.
27
  Blinder et al  (2001)  reviewed that  out of 249 
patients only 30 patients are reported bleeding.
35
 
This study used 5ml of 10% tranexamic acid solution whereas other studies 
used 10 ml of 4.8% tranexamic acid. It is possible that the smaller volume of 
tranexamic acid did not effectively reach the upper sockets, where the majority of 
bleeds occurred and was therefore less effective at preventing fibrinolysis. 
The present study with a bleeding rate of 8% requiring additional treatment, 
while slightly higher than other studies using a comparable technique, is considerably 
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less than studies involving extraction of teeth at therapeutic INR without topical 
antifibrinolytic mouthrinses. These report an incidence of bleeding between 21% and 
50% (Bailey and Fordyce, 1983; Sindet-Pedersen et al., 1989; Ramstrom et al., 1993). 
It may therefore be concluded that topical tranexamic acid mouthrinses effectively 
reduce postextraction bleeding. A particular benefit of this technique is its simplicity. 
Provided the patient has an INR below 3.5 at the time of surgery the teeth can be 
removed without significant risk.  
Surgery can be confidently scheduled with a definite date that avoids loss of 
operating time due to cancellations resulting from variable INR correction enabling 
tooth removal to proceed with minimum delay and inconvenience. 
Other techniques for managing patients on anti coagulants / anti platelets 
requiring tooth extraction are more potentially complicated. An INR reduction below 
2.0 cannot be guaranteed 2 days after stopping anti platelets / anti coagulants (Devani 
et al. 1998) and often takes 3 days. This delays treatment, increases the risk of 
thromboembolism, involves the patient's medical practitioner in reducing warfarin and 
necessitates extra tests to re-establish the INR following surgery. If the INR on the 
planned day of surgery is still above 2.0, surgery may be further delayed and required 
rescheduling the operation. Removal of teeth with an INR greater than 2.0, without 
using antifibrinolytic mouthrinses is associated with increased bleeding and this has 
the potential to cause further inconvenience. Heparin substitution requires 4 or 5 days 
hospitalization (Roser and Rosenbloom, 1975)
68
. This was both expensive and 
inconvenient. 
Statistical Interpretation: 
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The data was expressed in number, percentage, mean and standard deviation. 
Statistical Package for Social Sciences (SPSS 16.0) version used for analysis. 
Unpaired and Paired ‘t’ test applied to find the statistical significant between the 
groups. P values less than 0.05 (p<0.05) considered statistically significant at 95% 
confidence interval. 
Risk Factors for bleeding requiring management in the researcher's dental 
Surgery: 
Regardless of the method of statistical analysis used, there were several 
predictor variables strongly associated with an increased risk of bleeding managed in 
the researcher's dental surgery by local measures. These were a maxillary molar tooth, 
an INR equal to or greater than 2.5. This study also indicated that some areas of the 
mouth were especially prone to post extraction bleeding while other areas were 
relatively immune. Upper teeth bleed more than lower teeth. Molar teeth bleed more 
than all other teeth combined. The most common area for bleeding was the maxillary 
molar region and the least common the mandibular premolar, canine and incisor 
regions. Increased bleeding from the maxillary molar region was biologically 
plausible. First, maxillary molars are generally 3 rooted teeth and their removal leaves 
a wound with a large surface area. This is especially important if there is periodontal 
disease present with a large amount of granulation tissue. Because the wound was 
wide (bucco-palatally) it was generally not possible to close the wound and support 
the blood clot. Second, the maxilla was more vascular than the mandible.  
Traditionally, the INR had been used to determine how a patient on oral 
anticoagulants requiring dental extractions should be managed. Management has been 
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based on the assumption that the higher the INR the more likely a patient is to bleed. 
The present study found that there was no statistical difference between the incidence 
of bleeding below an INR of 2.5 and an INR equal to or above 2.5. However, this 
study confirmed that bleeding was significantly greater when the INR exceeded 3.0. 
From these results it was concluded that the incidence of bleeding does not greatly 
increase as the INR rises from 2.0 to 2.5 but with an INR of 2.5 and above the 
incidence of bleeding significantly increases. This finding was consistent with clinical 
experience and was biologically reasonable as anti coagulant and anti platelet causes 
impaired fibrin formation. The higher the INR, the more impaired the fibrin 
formation, therefore the more susceptible it was to fibrinolysis. The bleeding time test 
was not a significant determinant of post extraction bleeding. This was consistent with 
other evidence indicating that bleeding time was a poor predictor of surgical bleeding 
risk.  
Recommendations:   
On the basis of this study, several proposals can be made about the 
management of patients on anticoagulant / anti platelet. Of the 100 patients treated, 17 
reported bleeding at home on day 1 and 3 patients after day 1. The bleeding reported 
on these 20 patients was controlled at home only by tranexamic acid pressure pack 
alone. A further 9 patients reported to the researcher's dental surgery department for 
bleeding which was then controlled by administering other local hemostatic measures 
( gelatin foam ) with tranexamic acid pressure pack. No patients required hospital 
admission for systemic management of bleeding. 
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Statistical analysis reveals significant risk factors for postextraction bleeding 
were as follows: 
 Patients in the age group of  41-60;  
 Pre extraction INR equal to and greater than 2.5 ;  
 Smoking.   
Factors not statistically significant for an increased risk of bleeding included:  
 The number of teeth removed;  
 Pre-extraction bleeding time and 
 Time on anti platelets and anticoagulants. 
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In the past, optimal management of patients on anti coagulants / anti platelets 
who require oral surgery had been controversial. However, the technique described by 
Sindet-Pedersen et al. (1989) and used in this study provides a method of 
management that was safe, simple, effective and acceptable. The anticipated 
incidence of postextraction bleeding requiring management by local measures of 21-
50% without the use of antifibrinolytic mouthrinses was reduced to  9%  by using the 
antifibrinolytic mouthrinse tranexamic acid, 4 times a day for 7 days. Mouthrinse use 
was widely accepted with only 3% of patients strongly objecting to its use.   
A unique aspect of this study was the identification of factors that may 
predispose the patient to an increased risk of postextraction bleeding. These factors 
were: pre extraction INR equal to greater than 2.5; smoking. Factors not statistically 
significant for an increased risk of bleeding included: The number of teeth removed; 
pre-extraction bleeding time; time on anti platelets and anticoagulants. This study also 
found that upper sockets were more likely to bleed than lower sockets and that molar 
sockets were more likely to bleed than premolar, canine or incisor sockets.  
Identification of these factors gives a clinician an opportunity to implement 
strategies to reduce the likelihood of bleeding. These strategies might include either 
pre-extraction scaling of teeth to reduce gingival inflammation associated with deep 
periodontal pockets or excision of excess granulation tissue at the time of the 
extractions. Patients with factors that increase the risk of postextraction bleeding may 
require tranexamic acid mouthrinses for 10 days after extractions rather than the 
normal 7 days.  
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Finally concluded that the post-operative topical use of tranexamic acid 
mouthrinses in patients who underwent teeth removal at therapeutic INR levels was a 
safe, simple, effective and  acceptable method of reducing postextraction bleeding. 
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INFORMED CONSENT DOCUMENT (ICD) 
Patient / Participant information sheet 
INFORMATION FOR PARTICIPANTS OF THE STUDY 
Dear Volunteers, 
We welcome you and thank you for your keen interest in participation in 
this research project. Before you participate in this study, it is important for you to 
understand why this research is being carried out. This form will provide you all the 
relevant details of this research. It will explain the nature, the purpose, the benefits, 
the risks, the discomforts, the precautions and the information about how this project 
will be carried out. It is important that you read and understand the contents of the 
form carefully. This form may contain certain scientific terms and hence, if you have 
any doubts or if you want more information, you are free to ask the study personnel 
or the contact person mentioned below before you give your consent and also at any 
time during the entire course of the project. 
1. Title of the study: “Efficacy of Tranexamic Acid Mouthrinse as a Haemostatic 
Agent after Extraction in Patients who are on Anticoagulant and Anti Platelet 
Therapy” 
2. Name of the Principal Investigator: Dr. Abirami. K 
 Name of the Guide:   Dr. Mathew Jose. 
 Name of the Co-Guide: Dr. Dhineksh Kumar. 
3. Purpose of the study: 
The purpose of this study is,  patients on anti coagulanti / anti platelet  therapy  
who are going  for teeth  removal  while being maintained at therapeutic INR and 
using tranexamic acid  as mouthrinses post operatively to inhibit fibrinolysis, to: 
Verify that this technique is a relatively safe, simple, effective and acceptable 
method of managing these patients; 
Identify risk factors that may have potentiated the likelihood of bleeding. 
 
 
 
 
4. Procedure for the study:  
 Uncomplicated extraction be carried out under local anaesthetic in the 
dental chair using 2%lignocaine. Local anaesthetic will be administered following the 
standard dental protocol.The teeth will be removed using either forceps and/or 
elevators. Following delivery of the tooth, the wound is thoroughly irrigated with 10% 
tranexamic acid solution, care being taken not to suck this out of the socket.  
The socket wall is compressed using finger pressure over a swab soaked in 
tranexamic acid solution. The wound is then  closed using     3 '0' black silk suture.  
At the completion of surgery, the patient asked to bite on a pressure pad soaked in 
tranexamic acid solution. After 10 minutes the packwill be  removed and the wound 
observed. If bleeding has  stopped the patient can be  discharged with their home-care 
pack of tranexamic acid mouthrinse and post-operative instructions. 
If bleeding will not stop, the point of bleeding is identified and oxidised 
regenerated cellulose will be placed into the wound at this point. The patient is then 
asked to bite on a pressure pad soaked in tranexamic acid solution. After 10 minutes 
the pack is removed and the wound observed. If bleeding will stop the patient is then 
discharged with their home-care pack of tranexamic acid mouthrinse and post-
operative instructions. 
If bleeding will not stop, the point of bleeding is  identified. The sutures at that 
point were removed and the local area around the bleeding site is infiltrated with local 
anaesthetic The wound is then irrigated with 10 % tranexamic acid syrup and oxidised 
regenerated cellulose and/or gelatin sponge soaked in bovine thrombin solution 
inserted into the base of the oozing socket. The socket will be sutured with silk 
sutures and the patient asked to bite on a pressure pad soaked in tranexamic acid 
solution. After 20 minutes the pack is removed and the wound observed. If bleeding 
will stop  the patient is then discharged with their home-care pack of tranexamic acid 
mouthrinse and post-operative instructions. 
If the patient continues to bleed, this will be recorded. Consideration is given 
to an infusion of fresh frozen plasma /platelets or vitamin K, DDAVP. 
All details of this management and outcome were recorded. 
The patient will be discharged with the following items: 
 
 
a) 150ml, 10% tranexamic acid syrup plus 5 ml measure; 
b) Post-operative instructions/data collection sheet; 
c) Pressure swabs; 
d) Laboratory request form for post-extraction INR on day 4; 
e) Postextraction antibiotics (if required). 
5. Expected duration of the subject participation in the study:  1 Year 
6. Expected risks for the participants:     
Your involvement in this study is similar to other methods of managing tooth 
extraction patients who are on anticoagulants and antiplatelets. This is due to the 
need to attend the dental department a number of times plus the need to undergo 
blood tests. The prevention of bleeding depends on you using the tranexamic 
mouthrinse four times a day for seven days. Because you have not stopped taking 
your anticoagulant medication there is a small risk of bleeding. Biting on a 
pressure pack for ten minutes can normally control this bleeding. Occasionally it 
is possible that you may have to return to the dental department to have bleeding 
stopped by restitching the socket. On the rare occasion that these methods do not 
control bleeding you will be admitted to hospital and the bleeding controlled by an 
infusion of fresh frozen plasma. Other risks include the very small possibility of 
bruising or difficulty in opening your mouth following surgery. Again this is a risk 
associated with any dental extraction. Provided the tranexamic is used as a mouth 
rinse and spit out after holding in the mouth for 2 minutes, there is minimal 
adsorption into the body and therefore no risk of side effects. It has a somewhat 
bitter taste. 
7. Expected benefits of research for the participants: 
There are four main advantages of treating you by this method are: 
1)  Because your level of anticoagulation is maintained at an effective level 
there is no greater risk of forming blood clots during and after your 
treatment than normal. 
 
 
2)  Because your level of anticoagulation does not have to be adjusted you 
may be treated without delay. This is important if you are in pain or have 
an infection. 
3)  Because the level of anticoagulation is not altered you do not have the 
inconvenience of having your dose reduced and then re-established. This 
can be difficult. 
4)  The risk of bleeding is similar to other methods of management. 
8. Maintenance of confidentiality: 
 You have the right to confidentiality regarding the privacy of your medical 
information 
  (Personal details, results of physical examinations, investigations, and your 
medical history). 
 By signing this document, you will be allowing the research team 
investigators, other study Personnel, sponsors, institutional ethics committee 
and any person or agency required by law to view your data, if required.  
 The results of clinical tests and therapy performed as part of this research 
may be included in your medical record.  
 The information from this study, if published in scientific journals or 
presented at scientific meetings, will not reveal your identity. 
9.  Agreement of compensation to the participants (In case of a study related 
injury): 
  Patient will be taken care in case of complication and medical treatment will 
be provided in the institution. 
10. Compensation to the participants for forseeable risks and unforeseeable risks 
related to research study leading to disablilty or death? No risk to death, the 
patients treatment will be taken care by the investigator. 
11. Can I withdraw from the study at any time during the study period? 
   The participation in this research is purely voluntary and you have the right to 
withdraw from this study at any time during the course of the study without giving 
any reasons.  
 
 
However, it is advisable that you talk to the research team prior to stopping 
information. 
12. If there is any new findings/information, would I be informed?  Yes 
13.  Any other pertinent information? No other information  
14. Whom do I contact for further information? 
   For any study related queries, you are free to contact: 
Dr. Abirami K 
Post Graduate student. 
Department of Oral & Maxillofacial Surgery, 
Sree Mookambika Institute of Dental Sciences, 
Kulasekharam, Kanyakumari District-629161. 
Mobile No: 9789087197 
dr.abiramikesavan@gmail.com 
 
 
                            Signature of Principal 
Investigator 
  
Place:            Signature/ 
Thumb  
Date: impression of the 
participant 
      
 
 
 
 
 
 
CONSENT  FORM  (>18 years) 
PART 1OF 2 
PARTICIPANTS CONSENT FORM 
 
 The details of the study have been explained to me in writing and details have 
been fully explained to me. I am aware that the results of the study may not be 
directly beneficial to me but will help in the advancement of medical sciences. I 
confirm that I have understood the study and had the opportunity to ask questions. I 
understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reasons, without the medical care that 
normally be provided by the hospital being affected. I agree not to restrict the use of 
any data or results that arise from this study provided such a use is only for scientific 
purpose(s). I have given details of the study. I fully consent to participate in the study 
titled “Efficacy of Tranexamic Acid Mouthrinse as a Haemostatic Agent after 
Extraction in Patients who are on Anticoagulant and Anti Platelet Therapy”.  
 
Serial no/Reference no: 
Name of the participant:                                                       
Address of the Participant: 
 
Contact number of the Participant: 
 
Signature/Thumb impression of the participant/Legal guardian 
  Witness 
1. 
2. 
Date: 
Place: 
 
 
SREE MOOKAMBIKA INSTITUTE OF DENTAL SCIENCES 
DEPARTMENT OF ORAL AND MAXILLOFACIAL SURGERY 
LETTER TO MEDICAL PRACTITIONER / CARDIOLOGIST 
Dear Doctor,          Date :  
Name :....................................................                               Age/Sex  ................... 
I understand that the above person is a patient of yours. At the present time he 
/she is on oralanticoagulants but requires the removal of teeth. Traditionally this 
situation has been managed by reducing the oral anticoagulant level below INR 2.0. 
While the risk of bleeding is reduced there may be an increased risk of 
thromboembolism and problems associated with re-establishing atherapeutic level of 
anticoagulation. Recently an alternate method has been described where patients are 
maintained on a therapeutic dose of oral anticoagulant, the surgery is carried out, and 
postextraction rebleeding is prevented by the use of topical antifibrinolytic mouth 
rinses. We propose to fully document 100 cases looking at factors connected to 
anticoagulation, the surgery and rebleeding to determine which factors predispose to 
an increased risk of rebleeding and hence develop a profile of patients who can be 
managed by this method .  
............................................................... has consented to join this study and is booked 
for tooth extraction on . . . . . . . . . . . . . . . . . . . . . . . . . . . 
 Please maintain the patient on oral anticoagulant  within their normal 
therapeutic range. 
 I will arrange a pre-operative INR, APTT, FBC, BT followed by an INR four 
days post operation. Copies of these results will be sent to you.. 
 The patient is instructed to use tranexamic acid mouthrinse, 5ml, four times a 
day for seven days to prevent fibrinolysis. The solution is spat out after two 
minutes. 
 If bleeding occurs post-operatively the patient is instructed to bite on a swab 
for 20 minutes by the clock, if bleeding continues, then, during working hours 
they contact the OMFS department 
 If you have any concerns about your patient being included in this study, or 
wish to further information, please contact me at the department of OMFS 
(113) 
Thank you for your help. 
Yours sincerely, 
Dr.Abirami  K  II MDS
  
 
  
 
  
 
 
 
